Amparo Larrauri Cámara worked as a Senior Scientist in Public Research Organisation for Carlos III Health Institute, at National Centre of Epidemiology. She holds a degree in Pharmacy in 1980 and a doctorate in Biochemistry in 1988 at University of Valencia. She has more than 20 years of experience in vaccine preventable diseases surveillance and research. She has been the National Contact Point of the European Center of Disease, Prevention and Control (ECDC) for the Respiratory Viral Diseases Program until May 2024. She was the Head of the 32nd Research Group of the Cyber Epidemiology and Public Health (CIBERESP). Her research activity has focused on the study of the influenza disease burden and the effectiveness and impact of the influenza vaccine. She coordinated the implementation of the integrated respiratory surveillance system in Spain (SIVIRA) after the COVID-19 emergence.
Her main research interests are the effectiveness and impact of the influenza and COVID-19 vaccines and the evaluation of respiratory infection severity. She has coordinated the Spanish component of the I-MOVE, I-MOVE-COVID-19 and VEBIS projects. She was part of the National COVID vaccination effectiveness and impact monitoring group and of the technical Working Group of the Communication Strategy for vaccination against COVID-19, coordinated by the Ministry of Health, being a co-author of the National Vaccination Strategy, and an external expert for the European and Spanish Medicine Agencies.
Amparo Larrauri Cámara worked as a Senior Scientist in Public Research Organisation for Carlos III Health Institute, at National Centre of Epidemiology. She holds a degree in Pharmacy in 1980 and a doctorate in Biochemistry in 1988 at University of Valencia. She has more than 20 years of experience in vaccine preventable diseases surveillance and research. She has been the National Contact Point of the European Center of Disease, Prevention and Control (ECDC) for the Respiratory Viral Diseases Program until May 2024. She was the Head of the 32nd Research Group of the Cyber Epidemiology and Public Health (CIBERESP). Her research activity has focused on the study of the influenza disease burden and the effectiveness and impact of the influenza vaccine. She coordinated the implementation of the integrated respiratory surveillance system in Spain (SIVIRA) after the COVID-19 emergence.
Her main research interests are the effectiveness and impact of the influenza and COVID-19 vaccines and the evaluation of respiratory infection severity. She has coordinated the Spanish component of the I-MOVE, I-MOVE-COVID-19 and VEBIS projects. She was part of the National COVID vaccination effectiveness and impact monitoring group and of the technical Working Group of the Communication Strategy for vaccination against COVID-19, coordinated by the Ministry of Health, being a co-author of the National Vaccination Strategy, and an external expert for the European and Spanish Medicine Agencies.